A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase I clinical study that aims to assess the safety and immunogenicity of a novel, escalating dose regimen of R21/Matrix-M™ in healthy, malaria-naïve adults.
Epistemonikos ID: 1c3be94d4ad125d29c5b5801475fe7b2c7317c12
First added on: May 15, 2024